» Available Technologies

The following technologies are available for licensing. Please do not hesitate to contact Lawrence Lau, Director of Industry Alliances & Commercialization at lalau@chapman.edu for more information. 

Case Number

Invention Title

17-03

Rapid Selective Detection of Bacteria

18-01

"Novel neuronal nitric oxide synthase (nNOS) inhibitors for the immunotherapy of human melanoma patients", joint invention with Northwestern University

19-01

"Particles for Targeted Delivery and Uses in Managing Bleeding or Blood Clotting", joint invention with Emory University

19-04

Device for Treating Idiopathic Toe-Walking

2020-001

Targeting Primary Cilia with Nanoparticles

2020-004

Peptide/Lipid-Associated Nucleic Acids as a Multicomponent siRNA Delivery System 

2020-005

Targeted Peptide-Drug Conjugates to Overcome Multi-Drug Resistance in Cancer

2020-006 

Condensed Matter System with Ideal Diamagnetic Response at Room Temperature

2020-007

Flexible Substratum for
In Situ Single-Cell Observation

2020-008 Variable Light Diffuser for Plant Leaf Gas Exchange Measurements